Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson’s disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1756-6606
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson’s disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy ; volume:16 ; number:1 ; day:16 ; month:1 ; year:2023 ; pages:1-5 ; date:12.2023
Molecular brain ; 16, Heft 1 (16.1.2023), 1-5, 12.2023

Creator
Kim, Jieun
Han, Jung-Youn
Lee, Yujeong
Kim, Kipom
Choi, Young Pyo
Chae, Sehyun
Hoe, Hyang-Sook
Contributor
SpringerLink (Online service)

DOI
10.1186/s13041-023-00996-1
URN
urn:nbn:de:101:1-2023032421081212064416
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Kim, Jieun
  • Han, Jung-Youn
  • Lee, Yujeong
  • Kim, Kipom
  • Choi, Young Pyo
  • Chae, Sehyun
  • Hoe, Hyang-Sook
  • SpringerLink (Online service)

Other Objects (12)

Pioglitazone ameliorates the phenotype of a novel Parkinson’s disease mouse model by reducing neuroinflammation

Pioglitazone ameliorates the phenotype of a novel Parkinson’s disease mouse model by reducing neuroinflammation

Glycosphingolipids and neuroinflammation in Parkinson’s disease

Glycosphingolipids and neuroinflammation in Parkinson’s disease

Neuroinflammation and protein pathology in Parkinson’s disease dementia

Neuroinflammation and protein pathology in Parkinson’s disease dementia

MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease

MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease

LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?

LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?

Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop

Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop

Modeling Neuroinflammation in sporadic Parkinson ́s disease

Modeling Neuroinflammation in sporadic Parkinson ́s disease

Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of parkinson’s disease-lessons from transgenic mice

Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of parkinson’s disease-lessons from transgenic mice

NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson’s Disease

NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson’s Disease

Neuroinflammation in Parkinson’s disease – putative pathomechanisms and targets for disease-modification

Neuroinflammation in Parkinson’s disease – putative pathomechanisms and targets for disease-modification

CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease

CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease

The role of Toll-like receptors and neuroinflammation in Parkinson’s disease

The role of Toll-like receptors and neuroinflammation in Parkinson’s disease

Related objects